NF2 and meningioma: HERV-K expression has been observed in primary cells derived from patient meningiomas with NF2 mutations; further, FDA-approved retroviral protease inhibitors such as ritonavir, atazanavir, and lopinavir reduced the proliferation of grade 1 meningioma cells [59].